To the Editor Drs Stine and Chokshi1 suggested that with the arrival of the new American College of Cardiology/American Heart Association guidelines for lipid reduction to reduce adverse outcomes from atherosclerotic cardiovascular disease, it is time to move from a low-density lipoprotein cholesterol target basis to a “multifactorial risk assessment,” especially since online calculators now make it easy to perform quantitation and may even provide patient education tools (using simple natural frequency displays) to facilitate shared decision making.
Zelicoff AP. Multifactorial Risk Assessment for Atherosclerotic Cardiovascular Disease. JAMA. 2015;313(9):971-972. doi:10.1001/jama.2015.418